Cancer is a major public health problem throughout the world. Among the different forms of cancer, pancreatic cancer is the most aggressive one and has an exceptionally high global mortality rate. It ranks 7th as the most frequent cause of cancer death worldwide and has been estimated that the number of deaths from pancreatic cancer will reach 540,000 by 2030 [1] . As cancers increase in size, their immediate environment often becomes heterogeneous and some regions of large cancers often possess microenvironmental niches, which exhibit a significant gradient of critical metabolites including oxygen, glucose, other nutrients, and growth factors [2] . Thus, angiogenesis is regarded as the key step in tumor progression, and antiangiogenesis is the most promising cancer therapy; extensive studies have been conducted to prevent tumor angiogenesis. However, pancreatic cancer survives with an extremely poor blood supply and becomes more malignant [3] . It is also largely resistant to most known chemotherapeutic agents including 5-fluorouracil, Taxol ® , doxorubicin, cisplatin, and camptothecin [4] . Therefore, effective chemotherapeutic agents that target pancreatic cancer are urgently needed. Human pancreatic cancer cells show a remarkable tolerance to extreme nutrient starvation [5] , enabling them to survive under low nutrient conditions. Therefore, it has been hypothesized that eliminating the tolerance of cancer cells to nutrition starvation may allow a novel biochemical approach known as "anti-austerity" for cancer therapy [6] .
Considering this hypothesis, we screened medicinal plants of Japan, China, and Myanmar for antiausterity activity using the human pancreatic cancer cell line PANC-1 and identified their constituents with preferential cytotoxicity [7, 8] . Moreover, we examined the anti-austerity activity of eight medicinal plants used in Congolese traditional medicine and found that the CHCl 3 extracts from roots of Garcinia huillemsis (Clusiaceae), Securidaca longepedunculata (Polygalaceae), and Aflamomum melegueta (Zingiberaceae) displayed potent preferential cytotoxicity (PC 50 : 17.8, 23.4, and 47.8 μg/mL, respectively) against a human pancreatic cancer PANC-1 cell line in nutrient-deprived medium (NDM) [9] . We previously examined the constituents of the CHCl 3 extracts of G. huillensis [9] and S. longepedunculata [10] . In a continuing study of the preferentially cytotoxic constituents of Congolese medicinal plants, we recently examined the constituents of the CHCl 3 extract of the roots of A. melegueta. We herein report the active constituent together with the in vitro preferential cytotoxicity.
The CHCl 3 extract of the root of A. melegueta was separated by a combination of MPLC and preparative TLC techniques, which led to the isolation of ten compounds. They were identified by spectroscopic analyses and comparison with literature data to be two known dibenzyl--butyrolactone-type lignans [(-)-buplerol (1) [11] , (-)-arctigenin (2) [7] ], three known labdane-type diterpenes [(E)-14-hydroxy-15-norlabda-8(17),12-dien-16-al (3) [12] , labda-8(17),12-dien-15,16-dial (4) [13] , 16-oxo-8(17),12(E)-labdadien-15-oic acid (5) [14] ], and two known flavones [5-hydroxy-7methoxyflavone (6) [15] , and apigenin (7) [16] ] (Figure 1 ). The isolated compounds, except for (-)-arctigenin (2), the preferential cytotoxicity of which has been previously reported [7] , were evaluated for their in vitro preferential cytotoxicity against PANC-1 cells. Among the compounds tested, buplerol (1) revealed potent activity (PC 50 8.42 M) ( Figure 2 ), while the other constituents were inactive (PC 50 >100 M). Previously, we examined the preferential cytotoxicity of arctigenin and its related compounds and the following structural moieties were concluded to NPC Natural Product Communications 2015 Vol. 10 No. 6 997 -999 be important for the preferential cytotoxicity of arctigenin: 1) the 3hydroxy-4-methoxyphenyl group at the 2-position on the butyrolactone ring, 2) the less polar substituent at the 3-position on the -butyrolactone ring, 3) the -butyrolactone ring, and 4) the (2R,3R)-absolute configuration [17] . (-)-Buplerol (1) has the 3hydroxy-4-methoxyphenyl group at the 3-position on the butyrolactone ring instead of the 2-position on the -butyrolactone ring of (-)-arctigenin (2) . This could mean that the location of the lactone carbonyl group may not be important for the activity. Finally, we examined the mechanism of cell death induced by compound 1 in PANC-1 cells using phase contrast microscopic observation and a propidium iodide (PI)/annexin V double-staining method [18] . Phase contrast microscopic observation of the cells treated with 1 displayed the loss of membrane integrity and membrane blebbing (Figure 3a,b ). Furthermore, annexin V/PIstaining indicated that most cells were stained with annexin V on the cell membrane and with PI in the nucleus (Figure 3c,d) . These results suggest that 1 induced the apoptosis-like cell death of PANC-1 cells under nutrient starvation. Preferential cytotoxicity: Preferential cytotoxicity was determined as previously described [7, 8] . In brief, PANC-1 cells (2 × 10 4 cells/well) were seeded in 96-well plates (Corning Inc., Corning, NY, USA) and incubated in fresh DMEM at 37°C under 5% CO 2 and 95% air for 24 h. The cells were washed with Dulbecco's phosphate-buffered saline (PBS, Nissui Pharmaceutical Co., Ltd., Tokyo, Japan) before the medium was replaced with either DMEM or NDM containing serial dilutions of the test samples. After 24 h of incubation, the cells were washed with PBS, and 100 L of DMEM containing 10% WST-8 cell counting kit solution (Dojindo, Kumamoto, Japan) was added to the wells. After 3 h of incubation, the absorbance was measured at 450 nm. Cell viability was calculated from the mean values for 3 wells using the following equation: Cell viability (%) = [(Abs (test samples) -Abs (blank) )/(Abs (control) -Abs (blank) )] × 100. The preferential cytotoxicity was expressed as the concentration at which 50% of cells died preferentially in NDM (PC 50 ). (-)-Arctigenin and taxol, used as positive and negative controls, respectively, showed PC 50 values of 0.50 M and >100 M, respectively.
Morphological assessment of PANC-1 cells:
PANC-1 cells were seeded in 24-well plates (8 × 10 4 /well) and incubated in DMEM at 37°C under 5% CO 2 and 95% air for 24 h. The medium was replaced with NDM (100 L/well) with or without 8.8 M of 1. After 24 h incubation, cells were observed using a phase contrast microscope.
Annexin-V/PI staining: PANC-1 cells were seeded in 24-well plates (8 × 10 4 /well) and incubated in DMEM at 37°C under 5% CO 2 and 95% air for 24 h. The medium was replaced with NDM (400 L/well) with or without 50 M of 1 and 2. After 24 h incubation, cells were stained with Annexin-V-FLUOS Staining Kit (Roche Diagnostics GmbH, Penzberg, Germany), and the cells were observed using a fluorescent microscope (Biozero BZ-8000, Nikkon Eclipse TS 100 microscope, 40× objective). Cells stained by PI were detected with excitation and emission at 560 nm and 630 nm, respectively, while cells stained by annexin V were detected with excitation and emission at 480 nm and 510 nm, respectively.
